Nurix Therapeutics, Inc. NRIX Accumulated Depreciation
Accumulated Depreciation at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s accumulated depreciation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s accumulated depreciation?
- Nurix Therapeutics, Inc. (NRIX) reported accumulated depreciation of $39.72M in Q4 2025.
- How has Nurix Therapeutics, Inc.'s accumulated depreciation changed year-over-year?
- Nurix Therapeutics, Inc.'s accumulated depreciation increased by 8.1% year-over-year, from $36.76M to $39.72M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s accumulated depreciation?
- Over 3 years (2022 to 2025), Nurix Therapeutics, Inc.'s accumulated depreciation has grown at a 24.3% compound annual growth rate (CAGR), from $19.67M to $37.78M.
- What does accumulated depreciation mean?
- Total accumulated depreciation on property, plant, and equipment since acquisition — represents the consumed portion of asset useful lives.